NPS Platform is based on physical vapor deposition (PVD) Technology
NPS Makes drug nanoparticles with no excipients or solvents
NPS nanodrug particles can be used in pills, nasal sprays, creams/salves, inhalers, eye drops, or injectable
Universal application to all APIs that can be further processed into any existing dosage form
Rapid development of nanoformulation using minimal amount of API

Services

Rapid development time of 7 weeks unlike nano-emulsion, nano-crystals, or lipid-nanoparticles
Small development sample requirement of 7 grams unlike other enabling technologies
Low development cost unlike other processes
No chemicals, harsh solvents, or thermal degradation present in API nanoparticles.
PVD on generic hydrophilic carrier for feasibility
Analytical: Purity assay (Agilent 1100 Series HPLC) and particle size distribution (SHIMADZU SALD-2300)

Applications